Мировой рынок средств для растворения желчных камней – тенденции отрасли и прогноз до 2029 года

 Анализ и размер рынка  

Желчные камни — это затвердевшие отложения пищеварительной жидкости, которые образуются в желчном пузыре. Они могут состоять из холестерина, соли или билирубина и иметь различные размеры. Они могут варьироваться от песчинки до абрикоса. Желчные камни поражают 10–15 процентов населения США каждый год, или примерно 25 миллионов человек, согласно отчету Американской гастроэнтерологической ассоциации за 2017 год. Желчные камни становятся все более популярными, поскольку люди потребляют больше жиров и холестерина в своем рационе. Все эти факторы приводят к появлению на рынке средств, растворяющих желчные камни.

По данным Data Bridge Market Research, рынок средств для растворения желчных камней в 2021 году оценивался в 534,98 млн долларов США, а к 2029 году, как ожидается, достигнет 723,19 млн долларов США, что соответствует среднегодовому темпу роста в 4% в прогнозируемый период с 2022 по 2029 год. Отчет о рынке, подготовленный командой Data Bridge Market Research, включает в себя углубленный экспертный анализ, эпидемиологию пациентов, анализ линейки препаратов, анализ цен и нормативно-правовую базу.

Определение рынка

Химикаты, растворяющие желчные камни, растворяют небольшие некальцинированные желчные камни. Они уменьшают количество холестерина, вырабатываемого печенью, или предотвращают всасывание холестерина кишечником. Они используются для растворения желчных камней у людей, которым не требуется хирургическое вмешательство.

Область отчета и сегментация рынка

Gallstone Solubilizing Agents? Market Dynamics

Drivers

• Rise in the prevalence of gallbladder disease

The rising prevalence of gallbladder disease is anticipated to enhance the antifungal drugs market's growth rate. Along with this, the growing incidences of primary biliary cholangitis will propel the demand for gallstone solubilizing agents? in the market during the forecast period.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of gallstone solubilizing agents? market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the gallstone solubilizing agents? market. Additionally, high disposable income and changing lifestyle of people will result in the expansion of gallstone solubilizing agents? market. Along with this, rising geriatric population and favourable reimbursement scenario will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the gallstone solubilizing agents? market growth. The surge in drug approvals and new product launches will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will provide beneficial opportunities for the gallstone solubilizing agents? market growth during the forecast period.

Restraints/Challenges

On the other hand, the high cost associated with the drug development and distribution? will obstruct the growth rate of market. The lack of healthcare infrastructure in developing economies and low awareness among people will challenge the gallstone solubilizing agents? market. Additionally, side effects of gallstone solubilizing agents? including nausea, vomiting, dizziness, hair loss, back pain, cough, and others will act as market restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This gallstone solubilizing agents? market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gallstone solubilizing agents? market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Gallstone solubilizing agents? market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Gallstone Solubilizing Agents ? Market

Over the projected period, the gallstone solubilizing agents market is expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations have imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world are having difficulty continuing their supply chain activities. The supply chain slowness has also hampered the gallstone solubilizing agents? market.

Global Gallstone Solubilizing Agents? Market Scope

The gallstone solubilizing agents? market is segmented on the basis of drug type, application, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Type

• Ursodiol
• Chenodeoxycholic Acid

Application

• Gallbladder Disease
• Primary Biliary Cholangitis
• Others

Dosage Form

• Capsule
• Tablet
• Others

Route of Administration

• Oral
• Others

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Gallstone Solubilizing Agents Market Regional Analysis/Insights

The Gallstone solubilizing agents? market is analysed and market size insights and trends are provided by country, drug type, application, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Gallstone solubilizing agents? market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the gallstone solubilizing agents market because of the increase in the number of research and development activities in this region. Additionally, the growing presence of major key players and well-established healthcare infrastructure will further propel themarket's growth rate in this region.

Asia-Pacific are expected to grow during the forecast period of 2022 to 2029 due to rising healthcare expenditure and increasing government initiatives for the improvement of healthcare infrastructure in this region. Also, growing geriatric populations and rising level of disposable income with will further propel the market's growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Анализ конкурентной среды и доли рынка средств для растворения желчных камней

Конкурентная среда рынка растворителей желчных камней содержит сведения по конкурентам. Включены сведения о компании, финансы компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта, доминирование в применении. Приведенные выше данные относятся только к фокусу компаний, связанному с рынком растворителей желчных камней.

Некоторые из основных игроков, работающих на рынке средств для растворения желчных камней:

• Dipharma Francis Srl (Италия)
• ERREGIERRE SpA (Италия)
• Гриндекс (Латвия)
• ICE SpA (Италия)
• Zhongshan Belling Biotechnology Co.,Ltd. (Китай)
• Abil Chempharma Private Limited (Индия)
• Биотавия (Индия)
• DAEWOONG BIO (Южная Корея)
• PharmaZell GmbH (Германия)
• Suzhou Tianlu Bio-pharmaceutical Co., Ltd. (Китай)
• Glenmark Pharmaceuticals Limited (Индия)
• Корпорация Mitsubishi Tanabe Pharma (Япония) 

SKU-68130